Fig. 2From: Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancerScreening for EGFR exon 19 deletions and the T790M resistance mutation in two independent tumors (right versus left upper lung lobe) diagnosed synchronously. a Fragment-length analysis and Sanger sequencing demonstrating two different EGFR deletions in the two independent tumors. b SNaPshot analysis showing simultaneous emergence of the T790M resistance mutation in the two tumors after completion of EGFR TKI therapyBack to article page